| (h)MSC | (human) Messenchymal stem, cell |
| ACAN | Aggrecan |
| ADAMTS | A disintegrin and metalloproteinase with thrombospondin motifs |
| ADMSC | Adipose mesenchymal stem cell |
| AFMSC | Amniotic fluids mesenchymal stem cell |
| AKT | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| Bax | Bcl-2-associated X |
| Bcl-2 | B-cell lymphoma 2 |
| BDNF | Brain-derived neurotrophic factor |
| BMMSC | Bone marrow mesenchymal stem cell |
| cAMP | Cyclic adenosine monophosphate |
| CCP3 | ATP/GTP binding protein like 3 |
| CD- | Cluster of differentiation |
| CDH11 | Cadherin 11 |
| CDKN1A | Cyclin dependent kinase inhibitor 1A |
| CGPR | Calcitonin gene related protein |
| COL- I, II, 2A1 | Type I, II, 2A1 collagen |
| COL10A1 | Type X collagen |
| COMP | Cartilage oligomeric matrix protein (or thrombospodin 5) |
| CRPS | Complex regional pain syndrome |
| DKK-1 | Dickkopf WNT signaling pathway inhibitor 1 |
| DMEM | Dulbecco’s modified Eagle medium |
| ECM | Extracellular matrix |
| ELF3 | E74-like ETS transcription factor 3 |
| ERK | Extracellular-signal-regulated kinase |
| ESC | Embryonic stem cell |
| EV/EVs | Extracellular vesicles |
| FBS | Fetal bovine serum |
| FGF-2 | Fibroblast growth factor 2 |
| FoxO3 | Kruppel like factor 3-antisense RNA 1 |
| GIT1 | G-protein-coupled receptor kinase interacting protein 1 |
| H&E staining | Hematoxylin and eosin staining |
| HEK293 | Human embryonic kidney 293 cell |
| HGF | Hepatocyte growth factor |
| hiPSC | Human induced pluripotent stem cell |
| HUVEC | Human umbilical vein endothelial cell |
| IFN- | Interferon |
| IHC staining | Immunohistochemistry staining |
| IL- | Interleukin- |
| iNOS | Inducible nitric oxide synthase |
| KLF3-AS1 | Kruppel like factor 3-antisense RNA 1 |
| LFJ | Lumbar facet joint |
| LNA | Locked nucleic acid |
| lncRNA | Long noncoding ribonucleic acid |
| MAPK | Mitogen-activated protein kinase |
| MIA | Monosodium iodoacetate |
| miRNA | Micro ribonucleic acid |
| MISEV | Minimal Information for Studies of Extracellular Vesicles |
| MMP- | Matrix metalloproteinase- |
| mTOR | Mammalian target of Rapamycin |
| NF-kb | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | Nitric oxide |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| OA | Osteoarthritis |
| OCN | Osteocalcin |
| p38 | p38 mitogen-activated protein kinases |
| PGE2 | Prostaglandin E2 |
| PI3K-AKT | Phosphatidylinositol 3-kinase (PI3K) and Akt/Protein Kinase B |
| PRG4 | Proteoglycan 4 (or lubricin) |
| PTEN | Phosphatase and tensin homolog deleted on chromosome 10 |
| PTGS2 | Prostaglandin-endoperoxide synthase 2 |
| PWL | Paw withdrawal latency |
| PWT | Paw withdrawal threshold |
| RalA | Ras-related protein |
| RANK | Receptor activator of NF-κB |
| RANKL | RANK Ligand |
| RNA | Ribonucleic acid |
| RUNX2 | Runt-Related transcription factor 2 |
| s-GAG | Sulfate glycosaminoglycan |
| sgRNA | Single-guided ribonucleic acid |
| siRNA | Small interfering ribonucleic acid |
| Smad | “Small mothers against decapentaplegic” proteins family |
| SMSC | Synovial mesenchymal stem cell |
| SOX9 | SRY-related HMG-box 9 |
| STAT3 | Signal transducer and activator of transcription 3 |
| TEC | Tubular endothelial cell |
| TGF-β | Transforming growth factor beta |
| TIMP- | Tissue inhibitors of metalloproteinase- |
| TLR4 | Toll-like receptor 4 |
| TMJ-OA | Temporomandibular joint-osteoarthritis |
| TNF-α | Tumor necrosis factor-alpha |
| TRAF6 | Tumor necrosis factor receptor-associated factor 6 |
| UCMSC | Umbilical cord mesenchymal stem cell |
| Wnt5a/b | Wnt family member 5a/b |
| YAP | Yes-associated protein |
| Ym1 | Chitinase-like 3 |
| α-MEM | Minimum Essential Medium Eagle-α modification |